That's pretty much non-news in research. But - good to have any news on research progress.
It is mostly news due to getting the paperwork done for a phase-I study, that all expected to succeed. It isn't news on efficacy.
The in-vitro work they mention at the end is not interesting at all. In-vitro means in a little dish. They didn't even do it in-vivo in mice.
What we really need to hear is progress on any of the Phase-II trials.
If the price moved up on this it would only be on hope.
positive results for viralytics cavatak trial, page-8
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)